BIOMERICA INC
corporate_fare Company Profile
BIOMERICA INC (NASDAQ:RILY) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 34 items for RILY at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-08-28, rated 7/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 12 rated 8 or above. Recent SEC coverage for RILY spans SCHEDULE 13D, 8-K, 10-Q, 4.
Recent high-impact activity:
- B. Riley Secures 10% Stake in Biomerica with Board Seat and Strategic Advisory Mandate
- BRC Group Amends Oaktree Credit Agreement, Adds $3.1M Fee and New Borrowing Base Terms
- Trading Gains Fuel BRC Group's $191M Operating Profit as $69M Note Exchange Cuts Debt
- BRC Group Releases Holdback for Chairman Riley Citing 'Exemplary Performance'
- Compensation Committee Waives Holdback for Co-CEO Bryant Riley Due to Strong H1 2026 Performance
Financial Snapshot
Dilution Risk
Low riskFiling-implied dilution signals for RILY, detected from its recent SEC filings · based on capital-structure filings through 2026-06-09.
Debt-for-Equity Exchange · Significant Dilution
⚠ A more recent filing has been published for this ticker since this signal was computed; it may not yet be reflected — see the filings below.
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →